United States · Who invested in KAI Pharmaceuticals?
KAI Pharmaceuticals's investors include InterWest Partners, Intersouth Partners, Delphi Ventures, Skyline Ventures and Investor AB, and 2 more on record.
200420052006
$17MSeries A$35MSeries BUnited States · Series B startup
Who invested in KAI Pharmaceuticals
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$52Mraised across 2 rounds since 2003, from 2 sources
$17MSeries A$35MSeries B
- Latest round
- Series B, $35MMay 2006
- Step-upi
- 2.1×
- Investors
- 7
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $17M Dec 2003
- Biggest round
- $35M Series B · May 2006
- Between rounds
- 2.4 years from the last two
The rounds
- May 2006Series B$35M3 new4 returning
InterWest Partners
Intersouth Partners
Delphi Ventures
Investor AB
Aberdare Ventures
Skyline Ventures- MDS Capital
Reported by kaipharmaceuticals.com
- Dec 2003Series A$17M4 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
MDS CapitalGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about KAI Pharmaceuticals
How much has KAI Pharmaceuticals raised?
KAI Pharmaceuticals has raised $52M across 2 rounds since 2003.
When did KAI Pharmaceuticals last raise?
KAI Pharmaceuticals's most recent round was a Series B of $35M in May 2006.
What was KAI Pharmaceuticals's biggest round?
Its most recent round, $35M in May 2006, is also its largest on record.
Who backed KAI Pharmaceuticals first?
KAI Pharmaceuticals's first round on record, in Dec 2003, was backed by InterWest Partners, Intersouth Partners and Delphi Ventures and 1 others.
What stage is KAI Pharmaceuticals at?
KAI Pharmaceuticals's latest named round is a Series B, in May 2006.
Where is KAI Pharmaceuticals based?
KAI Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.